New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”

View/ Open
Issue date
2020Author
de Hollanda, Ana
Rubio, Miguel Ángel
Vilarrasa, Núria
Gregorio Oliva, José
Fernández-Soto, María Luisa
Salas-Salvadó, Jordi
Ballesteros-Pomar, María D.
Ciudin, Andreea
Torres, Ferran
Vidal, Concepción
Morales, María José
Valdés, Sergio
Pellitero, Silvia
Miñambres, Inka
Masmiquel, Lluís
Goday, Albert
Suarez, Lorena
Flores, Liliam
Bueno Díez, Marta
Caixàs, Assumpta
Bretón, Irene
Cámara, Rosa
Olbeyra, Romina
Penso, Rona
de la Cruz, María José
Simó-Servat, Andreu
Pereyra-García, Francisca María
López-Mezquita, Elena Teresa
Gils, Anna
Fidilio, Enzamaria
Bandrés, Orosia
Martínez, Ángel
Abuín, Jose
Marques-Pamies, Montserrat
Tuneu, Laura
Arteaga, Magdalena
Castañer, Olga
Goñi, Fernando
Arrizabalaga, Cristina
Botana, Manuel Antonio
Calañas, Alfonso
Suggested citation
de Hollanda, Ana;
Lecube Torelló, Albert;
Rubio, Miguel Ángel;
Sánchez Peña, Enric;
Vilarrasa, Núria;
Gregorio Oliva, José;
...
Calañas, Alfonso.
(2020)
.
New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”.
Journal of Clinical Medicine, 2020, vol. 9, núm. 4, p. 1070.
https://doi.org/10.3390/jcm9041070.
Metadata
Show full item recordAbstract
Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery
or are unable to sustain this effect long term. Our objective was to delve further into the dynamic
responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a
variable of metabolic control. A descriptive cohort study was done using a computerised multicentre
and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects
with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence
of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed.
All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2
) underwent
primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric
bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques
(p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly
negatively correlated with the “time-within-remission range”. The association of bariatric techniques
with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70
(2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve
gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric
surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to
sleeve gastrectomy
Is part of
Journal of Clinical Medicine, 2020, vol. 9, núm. 4, p. 1070European research projects
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by (c) de Hollanda, Ana et al., 2020
Related items
Showing items related by title, author, creator and subject.
-
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
Buxeda, Anna; Arias Cabrales, Carlos; Pérez Sáez, María José; Cacho, Judit; Cabello Pelegrin, Sheila; Melilli, Edoardo; Aladrén, María José; Galeano, Cristina; Lorenzo, Inmaculada; Mazuecos, Auxiliadora; Saura, Isabel María; Franco, Antonio; Ruiz Fuentes, María del Carmen; Sánchez Cámara, Luis Alberto; Siverio, Orlando; Martín Conde, María Luisa; González García, Elena; López, Verónica; Martin Moreno, Paloma Leticia; Moina, Iñigo; Moral Berrio, Esperanza; Moreso, Francesc; Portolés, José María; Santana Estupiñán, Raquel; Zárraga, Sofía; Canal, Cristina; Sánchez Álvarez, Emilio; Pascual, Julio; Crespo, Marta (Elsevier, 2021)Introduction:Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time torecovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acutekidney injury have ... -
Documento internacional de consenso sobre apnea obstructiva del sueño
Mediano, Olga; González Mangado, Nicolas; Montserrat, Josep Maria; Alonso Álvarez, María Luz; Almendros, Isaac; Alonso Fernández, Alberto; Barbé Illa, Ferran; Borsini, Eduardo; Caballero-Eraso, Candela; Cano-Pumarega, Irene; Carlos Villafranca, Felix Antonio De; Carmona Bernal, Carmen; Carrillo Alduenda, Jose Luis; Chiner, Eusebi; Cordero Guevara, Jose Aurelio; de Manuel, Luis; Durán-Cantolla, Joaquín; Farré, Ramon; Franceschini, Carlos; Gaig, Carles; García Ramos, Pedro; García-Río, Francisco; Garmendia, Onintza; Gómez García, Teresa; González Pondal, Silvia; Hoyo Rodrigo, Blanca M.; Lecube Torelló, Albert; Madrid, Juan Antonio; Maniegas Lozano, Lourdes; Martínez Carrasco, José Luis; Masa, Juan Fernando; Masdeu, María José; Mayós Pérez, Mercè; Mirabet Lis, Enrique; Monasterio, Carmen; Navarro Soriano, Nieves; Olea de la Fuente, Erika; Plaza, Guillermo; Puertas Cuesta, Francisco Javier; Rabec, Claudio; Resano, Pilar; Rigau, David; Roncero, Alejandra; Ruiz, Concepción; Salord, Neus; Saltijeral, Adriana; Sampol, Gabriel; Sánchez Quiroga, María Ángeles; Sans Capdevila, Oscar; Teixeira, Carlos; Tinahones, Francisco José; Togeiro, Sonia María; Troncoso Acevedo, Maria Fernanda; Vargas Ramírez, Leslie Katherine; Winck, Joao; Zabala Urionaguena, Nerea; Egea, Carlos (Elsevier, 2021)Themainaimofthis international consensusdocument onobstructive sleepapnea is toprovide guidelines based on a critical analysis of the latest literature to help health professionals make the best decisions in the care of ... -
Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial
Pujol, Miquel; Miró, José María; Shaw, Evelyn; Aguado, Jose María; San Juan, Rafael; Puig Asensio, Mireia; Pigrau, Carles; Calbo Sebastian, Esther; Montejo, Miguel; Rodríguez Álvarez, Regino; García Pais, María Jose; Pintado, Vicente; Escudero Sánchez, Rosa; López Contreras, Joaquín; Morata, Laura; Montero, Milagros; Andrés, Marta; Pasquau, Juan; Arenas, María del Mar; Padilla, Belén; Murillas, Javier; Jover, Alfredo; López Cortes, Luis Eduardo; García Pardo, Graciano; Gasch, Oriol; Videla, Sebastian; Hereu, Pilar; Tebé, Cristian; Pallarès, Natalia; Sanllorente, Mireia; Domínguez, María Ángeles; Càmara, Jordi; Ferrer, Anna; Padullés, Ariadna; Cuervo, Guillermo; Carratalà, Jordi (Oxford University Press; Infectious Diseases Society of America, 2021)Background. We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis.Methods. A ...